Mammoth Biosciences Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 110
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $150M
Latest Deal Amount
  • Investors
  • 26

Mammoth Biosciences General Information

Description

Developer of a CRISPR-based detection platform intended to democratize disease detection. The company's platform provides an easy and affordable point-of-need test that allows rapid and simultaneous detection of multiple conditions, enabling healthcare providers, researchers, and biotech professionals to have access to an efficient platform for molecular diagnostics.

Contact Information

Website
www.mammoth.bio
Formerly Known As
Apheleia Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Other Healthcare Services
Primary Office
  • 1000 Marina Boulevard
  • Suite 600
  • Brisbane, CA 94005
  • United States
+1 (650) 000-0000

Mammoth Biosciences Timeline

2018201920202021
Date FoundedFinancing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mammoth Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 09-Sep-2021 $150M 00000 00.000 Completed Generating Revenue
5. Later Stage VC (Series C) 19-May-2020 0000 00000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 30-Jan-2020 0000 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Jul-2018 0000 000.00 0000 Completed Generating Revenue
2. Accelerator/Incubator 24-Jan-2018 $120K Completed Generating Revenue
1. Accelerator/Incubator 15-May-2017 $120K $120K 0000 Completed Startup
To view Mammoth Biosciences’s complete valuation and funding history, request access »

Mammoth Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-1 0,000,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series D 00,000,000 00.000000 00 000.00 000.00 00 000.00 0.00
Series C-1 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 13,631,447 $0.000100 8% $2.7 $2.7 1x $2.7 17.06%
Series A 18,051,205 $0.000100 8% $1 $1 1x $1 22.59%
To view Mammoth Biosciences’s complete cap table history, request access »

Mammoth Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a CRISPR-based detection platform intended to democratize disease detection. The company's platform provide
Biotechnology
Brisbane, CA
110 As of 2021
00000
0.000 0000-00-00
00000000000 00000

00000000

iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
0000000000 000000000
San Diego, CA
00 As of 0000
000.00
00000000

00000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
0.000 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mammoth Biosciences Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Decipher Urologic Cancers Venture Capital-Backed San Diego, CA 00 000.00 00000000
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
00000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 000 Formerly VC-backed Cambridge, MA 0000 00000 000000000 00000
00000000 Venture Capital-Backed Redwood City, CA 000 00000 00000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Mammoth Biosciences Patents

Mammoth Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210009974-A1 Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection Pending 04-Jan-2019 0000000000
US-20210102242-A1 Programmable nuclease compositions and methods of use thereof Pending 01-Aug-2018 0000000000
EP-3830301-A1 Programmable nuclease compositions and methods of use thereof Pending 01-Aug-2018 0000000000
US-20210078002-A1 Programmable nuclease compositions and methods of use thereof Pending 01-Aug-2018 C12Q1/6816

Mammoth Biosciences Executive Team (9)

Name Title Board Seat Contact Info
Trevor Martin Ph.D Co-Founder and Chief Executive Officer
Ted Tisch Chief Operating Officer
Janice Chen Ph.D Co-Founder and Chief Technology Officer
Lucas Harrington Co-Founder and Chief Science Officer
Jerome Lansangan Controller
You’re viewing 5 of 9 executive team members. Get the full list »

Mammoth Biosciences Board Members (3)

Name Representing Role Since
Jennifer Doudna Ph.D Mammoth Biosciences Co-Founder & Chair of Scientific Advisory Board 000 0000
Ursheet Parikh Mayfield (Private Equity) Board Member 000 0000
Victor Tong Jr. Decheng Capital Board Member 000 0000
To view Mammoth Biosciences’s complete board members history, request access »

Mammoth Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mammoth Biosciences Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Senator Investment Group Hedge Fund Minority 000 0000 000000 0
Sixth Street Partners Growth/Expansion Minority 000 0000 000000 0
Amazon.com Corporation Minority 000 0000 000000 0
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
Redmile Group Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »